Cargando…
Impact of Angiographic Residual Stenosis on Clinical Outcomes After New‐Generation Drug‐Eluting Stents Implantation: Insights From a Pooled Analysis of the RESET and NEXT Trials
BACKGROUND: Previous intravascular ultrasound studies suggested the association of stent underexpansion with increased risk of stent thrombosis and restenosis. However, no previous study has addressed the association of the suboptimal angiographic result with target‐lesion revascularization (TLR) in...
Autores principales: | Watanabe, Hiroki, Morimoto, Takeshi, Shiomi, Hiroki, Natsuaki, Masahiro, Kawai, Kazuya, Kozuma, Ken, Igarashi, Keiichi, Kadota, Kazushige, Tanabe, Kengo, Morino, Yoshihiro, Hibi, Kiyoshi, Akasaka, Takashi, Abe, Mitsuru, Suwa, Satoru, Muramatsu, Toshiya, Kobayashi, Masakazu, Dai, Kazuoki, Nakao, Koichi, Tarutani, Yasuhiro, Fujii, Kenshi, Kimura, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064905/ https://www.ncbi.nlm.nih.gov/pubmed/29960987 http://dx.doi.org/10.1161/JAHA.118.008718 |
Ejemplares similares
-
Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
por: Natsuaki, Masahiro, et al.
Publicado: (2018) -
Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke
por: Natsuaki, Masahiro, et al.
Publicado: (2019) -
Prognostic Impact of Baseline Hemoglobin Levels on Long‐Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions
por: Nagao, Kazuya, et al.
Publicado: (2019) -
One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial
por: Natsuaki, Masahiro, et al.
Publicado: (2015) -
One-year clinical outcomes of patients with versus without acute coronary syndrome with 3-month duration of dual antiplatelet therapy after everolimus-eluting stent implantation
por: Natsuaki, Masahiro, et al.
Publicado: (2020)